|
| Status |
Public on May 24, 2023 |
| Title |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by array
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
37407815 |
| |
| Submission date |
Jul 31, 2022 |
| Last update date |
Jul 24, 2023 |
| Contact name |
Hongbo Chi |
| E-mail(s) |
hongbo.chi@stjude.org
|
| Organization name |
St Jude Children's Research Hospital
|
| Department |
Immunology
|
| Street address |
262 Danny Thomas Place
|
| City |
Memphis |
| State/province |
TN |
| ZIP/Postal code |
38105 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL23038 |
[Clariom_S_Mouse] Affymetrix Clariom S Assay, Mouse (Includes Pico Assay) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (25)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE210148 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [array] |
| GSE210151 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [ATAC-Seq] |
| GSE210153 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [scRNA-Seq 1] |
| GSE210154 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [scRNA-Seq 2] |
|
| Relations |
| BioProject |
PRJNA864050 |
Less...
More...